Fierce Biotech February 8, 2024
It’s electric! A startup emerged from stealth this week with grand plans to pioneer a new form of neurotech dubbed “electric medicine.”
Elemind’s approach centers on artificial intelligence-powered algorithms that are trained to continuously analyze neurological activity collected by a noninvasive wearable device, then to deliver through the wearable bursts of neurostimulation that are uniquely tailored to those real-time brain wave readings.
The Cambridge, Massachusetts-based company claims that its approach—which is based on research from its founders, a group of high-profile scientists hailing from the likes of MIT, Stanford and Harvard—offers a more “natural” treatment option than pharmaceuticals for neurological conditions like insomnia, essential tremor and memory loss.
“Chemical drugs affect the entire body, often leading to unwanted side effects....
Today's Sponsors
Today's Sponsor